WHO South-East Asia Journal of Public Health
  • 465
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
POLICY AND PRACTICE
Year : 2014  |  Volume : 3  |  Issue : 1  |  Page : 75-80

Mass primaquine preventive treatment for control of Plasmodium vivax malaria in the Democratic People’s Republic of Korea: a country success story


1 Office of the WHO Representative, 14-Munsudong, Pyongyang, Democratic People’s Republic of Korea
2 Ministry of Public Health, Democratic People’s Republic of Korea
3 Office of the WHO Representative, Bangkok, Thailand

Correspondence Address:
Shushil Dev Pant
Office of the WHO Representative, 14-Munsudong, Pyongyang
Democratic People’s Republic of Korea
Login to access the Email id


DOI: 10.4103/2224-3151.206889

PMID: 28607259

Rights and Permissions

In 1998, the resurgence of Plasmodium vivax malaria in the Democratic People’s Republic of Korea quickly increased to an epidemic, with 601 013 cases reported I during 1999–2001. The introduction of mass primaquine preventive treatment (MPPT) in 2002 was followed by a rapid reduction of malaria disease burden. The intervention has been well accepted by the community. Doctors were part of a strong functional health system with the ability to deliver interventions at the household J level. MPPT was considered for control of malaria after a study conducted in two J neighbouring endemic villages (ris) involving 320 healthy adults demonstrated that presence of parasitaemia was significantly lower among those receiving MPPT than those who did not. Similarly, in a mass blood survey conducted in the study sites during May, 2002 involving 5138 persons in study and 4215 in comparison areas, the total positive results were 7–10 times rarer in the treatment group both before and after the malaria transmission season. In addition, the number of malaria cases in the MPPT treatment ris was strikingly lower than control ris in every month during the malaria transmission season of 2002. The prevalence of G6PDD deficiency in DPR Korea is low, haemolytic events are rare and deaths due to MPPT have not been reported. MPPT in itself is a powerful intervention and the decision to deploy it depends on the epidemiology of malaria, urgency of malaria control and resources available in the country.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed626    
    Printed10    
    Emailed0    
    PDF Downloaded81    
    Comments [Add]    
    Cited by others 4    

Recommend this journal